AI assistant
Sending…
Vericel Corp — Director's Dealing 2013
May 3, 2013
31799_dirs_2013-05-03_281da3b1-c6df-4336-a131-8dc617f093ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2013-05-02
Reporting Person: ZERBE ROBERT L MD (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-02 | Stock option (right to buy) | $.53 | A | 60000 | Acquired | 2023-05-02 | Common stock (60000) | Direct |
Footnotes
F1: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
More from Vericel Corp
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Mar 19
Annual Report
2026
Mar 19